Approval · Notice of Compliance 8010 · 2006
ALTACE: Notice of Compliance 8010
Issued June 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8010
- Date
- June 2, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New 15 mg strength
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALTACE | 02281112 | Dormant |
Medicinal ingredients
- RAMIPRIL 15 MG per CAP